CONMED Corporation
CNMD
$34.03
-$0.74-2.13%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 129.09% | -50.41% | -94.16% | -28.54% | -69.37% |
| Total Depreciation and Amortization | 3.20% | 6.29% | 3.52% | 4.10% | 1.19% |
| Total Amortization of Deferred Charges | -11.57% | -3.69% | -11.57% | -1.28% | 2.56% |
| Total Other Non-Cash Items | -74.66% | 80.00% | 152.23% | 1,222.22% | 872.18% |
| Change in Net Operating Assets | -3,922.64% | 32.91% | 1,664.35% | -218.86% | 105.49% |
| Cash from Operations | -67.56% | 6.92% | 4.85% | -32.73% | 42.63% |
| Capital Expenditure | 23.47% | -26.51% | -51.71% | -59.58% | -85.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 240.25% | -76.01% | -51.71% | -59.58% | -43.93% |
| Total Debt Issued | 8.43% | 24.67% | 16.78% | -1.63% | -34.65% |
| Total Debt Repaid | 14.17% | -11.29% | -15.98% | 7.97% | 24.12% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -0.23% | -0.42% | -0.45% | -0.44% |
| Other Financing Activities | -38.09% | -25.71% | -25.01% | 21.67% | 71.59% |
| Cash from Financing | 20.58% | 26.83% | -12.09% | 39.83% | -66.91% |
| Foreign Exchange rate Adjustments | -199.39% | 101.52% | -96.90% | 354.78% | 259.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.49% | 113.48% | -47.97% | 68.91% | 15.35% |